Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Overview

This protocol outlines the induction and scoring of xenograft-versus-host disease (xenoGVHD) in a mouse model. It provides a method to study human T cell immunosuppression in vivo, enhancing the relevance of findings to clinical applications.

Key Study Components

Area of Science

• Immunology
• Xenotransplantation
• Translational Medicine

Background

• XenoGVHD serves as a model to study human T cell behavior.
• It allows for the testing of immunosuppressive therapies in a relevant biological context.
• The model improves the translation of research findings to human clinical scenarios.
• Standardized scoring ensures reliable and reproducible results.

Purpose of Study

• To establish a reliable xenoGVHD model for research.
• To quantify human T cell immunosuppression using digital PCR.
• To improve the understanding of human immune responses in a controlled environment.

Methods Used

• Induction of xenoGVHD in NSG mice through irradiation.
• Isolation of human peripheral blood mononuclear cells (PBMCs) for injection.
• Standardization of clinical scoring methods for consistency.
• Use of digital PCR for quantifying human T cells in tissues.

Main Results

• Successful induction of xenoGVHD in the mouse model.
• Reliable scoring methods established for assessing disease severity.
• Quantification of human T cells demonstrated through digital PCR.
• Insights gained into the immunosuppressive effects on human T cells.

Conclusions

• The xenoGVHD model is a valuable tool for studying human immunology.
• Standardized methods enhance the reproducibility of results.
• Findings may inform future clinical applications of immunosuppressive therapies.

Frequently Asked Questions